These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 31884334

  • 1. Risk of second primary papillary thyroid cancer among adult cancer survivors in the United States, 2000-2015.
    Schonfeld SJ, Morton LM, Berrington de González A, Curtis RE, Kitahara CM.
    Cancer Epidemiol; 2020 Feb; 64():101664. PubMed ID: 31884334
    [Abstract] [Full Text] [Related]

  • 2. Risk of Subsequent Primary Kidney Cancer After Another Malignancy: A Population-based Study.
    Abdel-Rahman O.
    Clin Genitourin Cancer; 2017 Oct; 15(5):e747-e754. PubMed ID: 28314541
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
    Kutsenko A, Berrington de Gonzalez A, Curtis RE, Rajaraman P.
    Cancer Causes Control; 2014 Jun; 25(6):659-68. PubMed ID: 24682745
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Second malignancy risks after non-Hodgkin's lymphoma and chronic lymphocytic leukemia: differences by lymphoma subtype.
    Morton LM, Curtis RE, Linet MS, Bluhm EC, Tucker MA, Caporaso N, Ries LA, Fraumeni JF.
    J Clin Oncol; 2010 Nov 20; 28(33):4935-44. PubMed ID: 20940199
    [Abstract] [Full Text] [Related]

  • 11. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP, Clarke CA, Aroner S, Swetter SM.
    J Am Acad Dermatol; 2010 May 20; 62(5):757-67. PubMed ID: 20223559
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk of second primary thyroid cancer in cancer survivors.
    Yuan Y, Sun P, Xiao H, Li L, Li J, Ai X.
    Sci Rep; 2024 May 30; 14(1):12478. PubMed ID: 38816510
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Second primary cancer risks according to race and ethnicity among U.S. breast cancer survivors.
    Brandt C, Vo JB, Gierach GL, Cheng I, Torres VN, Lawrence WR, McCullough LE, Veiga LHS, Berrington de González A, Ramin C.
    Int J Cancer; 2024 Sep 15; 155(6):996-1006. PubMed ID: 38685564
    [Abstract] [Full Text] [Related]

  • 18. Risk of subsequent myeloid neoplasms after radiotherapy treatment for a solid cancer among adults in the United States, 2000-2014.
    Teepen JC, Curtis RE, Dores GM, Berrington de Gonzalez A, van den Heuvel-Eibrink MM, Kremer LCM, Gilbert ES, van Leeuwen FE, Ronckers CM, Morton LM.
    Leukemia; 2018 Dec 15; 32(12):2580-2589. PubMed ID: 29795414
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.